Cargando…

Serum CA 15-3 assay in the diagnosis and follow-up of breast cancer.

Serum CA 15-3 values were determined in 177 patients with primary breast cancer and in 41 with non-malignant breast disease. Increased preoperative serum CA 15-3 values (greater than 38 U ml-1) were observed in 7%, 17%, 64% and 67% of patients with stage I, II, III and IV disease, respectively and i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kallioniemi, O. P., Oksa, H., Aaran, R. K., Hietanen, T., Lehtinen, M., Koivula, T.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1988
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246767/ https://www.ncbi.nlm.nih.gov/pubmed/3166913

Ejemplares similares

Tumour DNA ploidy as an independent prognostic factor in breast cancer.
por: Kallioniemi, O. P., et al.
Publicado: (1987)

Lectin nanoparticle assays for detecting breast cancer-associated glycovariants of cancer antigen 15-3 (CA15-3) in human plasma
por: Terävä, Joonas, et al.
Publicado: (2019)

Value of CA 15:3 in the follow-up of breast cancer patients.
por: Pons-Anicet, D. M., et al.
Publicado: (1987)

Evaluation of serum CA15-3 determination with CEA and TPA in the post-operative follow-up of breast cancer patients.
por: Nicolini, A., et al.
Publicado: (1991)

Clinical significance of serum CA15-3 as a prognostic parameter during follow-up periods in patients with breast cancer
por: Chu, Won Gong, et al.
Publicado: (2016)

Serum CA549 in primary breast cancer: comparison with CA15.3 and MCA.
por: Gion, M., et al.
Publicado: (1994)

Use of CA15-3 for screening breast cancer: An antibody-lectin sandwich assay for detecting glycosylation of CA15-3 in sera
por: Choi, Jae Woong, et al.
Publicado: (2018)

Clinical Value of Serum S100A8/A9 and CA15-3 in the Diagnosis of Breast Cancer
por: Khorrami, Samaneh, et al.
Publicado: (2019)

Prognostic Impact of Elevation of Cancer Antigen 15-3 (CA15-3) in Patients With Early Breast Cancer With Normal Serum CA15-3 Level
por: Ryu, Jai Min, et al.
Publicado: (2023)

Serum CEA and CA 15-3 as prognostic factors in primary breast cancer
por: Ebeling, F G, et al.
Publicado: (2002)

Comparison of mammary serum antigen (MSA) and CA15-3 levels in the serum of patients with breast cancer.
por: Sacks, N. P., et al.
Publicado: (1987)

Intensive post-operative follow-up of breast cancer patients with tumour markers: CEA, TPA or CA15.3 vs MCA and MCA-CA15.3 vs CEA-TPA-CA15.3 panel in the early detection of distant metastases
por: Nicolini, Andrea, et al.
Publicado: (2006)

CA15.3 Serum Concentrations in Older Women with Infiltrating Ductal Carcinomas of the Breast
por: Ruibal, Álvaro, et al.
Publicado: (2014)

Correlation between salivary and serum CA15-3 concentrations in patients with breast cancer
por: Assad, Daniele Xavier, et al.
Publicado: (2020)

Correlation of cancer antigen 15-3 (CA15-3) serum level and bony metastases in breast cancer patients
por: Fakhari, Ashraf, et al.
Publicado: (2019)

Association of Preoperative Serum Levels of CEA and CA15-3 with Molecular Subtypes of Breast Cancer
por: Zhao, Wenjing, et al.
Publicado: (2021)

CA15-3 is a useful serum tumor marker for diagnostic integration of hybrid positron emission tomography with integrated computed tomography during follow-up of breast cancer patients
por: Incoronato, Mariarosaria, et al.
Publicado: (2014)

CA 15-3 is predictive of response and disease recurrence following treatment in locally advanced breast cancer
por: Al-azawi, Dhafir, et al.
Publicado: (2006)

Loneliness and psychological distress before and during the COVID-19 pandemic: Relationships with social media identity bubbles
por: Latikka, Rita, et al.
Publicado: (2022)

Utility of C-erbB-2 in tissue and in serum in the early diagnosis of recurrence in breast cancer patients: comparison with carcinoembryonic antigen and CA 15.3.
por: Molina, R., et al.
Publicado: (1996)

Discordant results between radioligand and immunohistochemical assays for steroid receptors in breast carcinoma.
por: Helin, H., et al.
Publicado: (1990)

An evaluation of preoperative CA 15-3 measurement in primary breast carcinoma.
por: O'Hanlon, D. M., et al.
Publicado: (1995)

PLA2G7 associates with hormone receptor negativity in clinical breast cancer samples and regulates epithelial‐mesenchymal transition in cultured breast cancer cells
por: Lehtinen, Laura, et al.
Publicado: (2017)

An individual reference limit of the serum CEA–TPA–CA 15-3 tumor marker panel in the surveillance of asymptomatic women following surgery for primary breast cancer
por: Nicolini, Andrea, et al.
Publicado: (2018)

FTO, PIK3CB serve as potential markers to complement CEA and CA15-3 for the diagnosis of breast cancer
por: Mi, Jintao, et al.
Publicado: (2023)

A Panel of CA19-9, Ca125, and Ca15-3 as the Enhanced Test for the Differential Diagnosis of the Pancreatic Lesion
por: Hogendorf, Piotr, et al.
Publicado: (2017)

CA-125: a marker for diagnosis and follow-up of pleuroperitoneal and lymph node tuberculosis
por: Wani, Abdul Majid, et al.
Publicado: (2008)

CA125-Tn ELISA assay improves specificity of pre-operative diagnosis of ovarian cancer among patients with elevated serum CA125 levels
por: Wang, Yi-Sheng, et al.
Publicado: (2021)

Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast Cancer
por: Shao, Yingbo, et al.
Publicado: (2015)

A Giant Simple Liver Cyst That Caused Increases in Serum CA 19-9 and CA 15-3 Levels
por: Dinc, Bulent, et al.
Publicado: (2014)

Thioredoxin 1 as a serum marker for breast cancer and its use in combination with CEA or CA15-3 for improving the sensitivity of breast cancer diagnoses
por: Park, Byung-Joon, et al.
Publicado: (2014)

Menstrual Cycle Dependent Variability for Serum Tumor Markers CEA, AFP, CA 19-9, CA 125 and CA 15-3 in Healthy Women
por: Erbağci, Ayşe Binnur, et al.
Publicado: (1999)

Concordance of Hypermethylated DNA and the Tumor Markers CA 15-3, CEA, and TPA in Serum during Monitoring of Patients with Advanced Breast Cancer
por: Kristiansen, Søren, et al.
Publicado: (2015)

Assessing Clinical Significance of Serum CA15-3 and Carcinoembryonic Antigen (CEA) Levels in Breast Cancer Patients: A Meta-Analysis
por: Fu, Yijie, et al.
Publicado: (2016)

High-throughput RNAi screening for novel modulators of vimentin expression identifies MTHFD2 as a regulator of breast cancer cell migration and invasion
por: Lehtinen, Laura, et al.
Publicado: (2012)

Detection of secondary metastatic breast cancer by measurement of plasma CA 15.3
por: De Cock, L., et al.
Publicado: (2021)

The tumour associated antigen CA15.3 in primary breast cancer. Evaluation of 667 cases.
por: Gion, M., et al.
Publicado: (1991)

Diagnostic Value of Neuron-Specific Enolase (NSE) and Cancer Antigen 15-3 (CA 15-3) in the Diagnosis of Pleural Effusions
por: Saba, Mohammad Ali, et al.
Publicado: (2017)

Regulation and Trust: 3-Month Follow-up Study on COVID-19 Mortality in 25 European Countries
por: Oksanen, Atte, et al.
Publicado: (2020)

Evaluation of a newly developed quantitative determination kit for tumor marker CA15‐3 with chemiluminescent assay
por: Li, Peihua, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_5be1d1t1ak52ot0ffvo3lm8gq5